skip to main content
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal of Hepatology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with chronic hepatitis B
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with chronic hepatitis B

Tak, W.Y. ; W-L, Chuang ; C-Y, Chen ; K-C, Tseng ; Y-S, Lim ; G-H, Lo ; Heo, J. ; Agarwal, K. ; Bussey, L. ; Teoh, S.L. ; Tria, A. ; Brown, A. ; Anderson, K. ; Vardeu, A. ; O’Brien, S. ; Kopycinski, J. ; Rutkowski, K. ; Kolenovska, R. ; Barnes, E. ; Evans, T.G.

Journal of hepatology, 2024-07 [Periódico revisado por pares]

Texto completo disponível

2
Fractalkine-CX3CR1 is the only predictor for mortality in hepatocellular carcinoma patients treated with curative radiofrequency ablation
Material Type:
Artigo
Adicionar ao Meu Espaço

Fractalkine-CX3CR1 is the only predictor for mortality in hepatocellular carcinoma patients treated with curative radiofrequency ablation

Teng, W ; Jeng, W.-J ; Chen, W.-T ; Hsieh, Y.-C ; Huang, C.-H ; Lin, C.-C ; Lin, S.-M ; Chen, Y.-C ; Lin, C.-Y ; Sheen, I-S

Journal of hepatology, 2017, Vol.66 (1), p.S637-S637 [Periódico revisado por pares]

Texto completo disponível

3
Ledipasvir/sofosbuvir for 12 weeks is safe and effective in patients with chronic hepatitis C and hepatitis B coinfection: A phase 3 study in Taiwan
Material Type:
Artigo
Adicionar ao Meu Espaço

Ledipasvir/sofosbuvir for 12 weeks is safe and effective in patients with chronic hepatitis C and hepatitis B coinfection: A phase 3 study in Taiwan

Liu, C.-J ; Chuang, W.-L ; Sheen, I.-S ; Wang, H.-Y ; Chen, C.-Y ; Tseng, K.-C ; Chang, T.-T ; Massetto, B ; Yang, J ; Camus, G ; Zhang, F ; Brainard, D.M ; McHutchison, J.G ; Hu, T.-H ; Hsu, Y.-C ; Lo, G.-H ; Chu, C.-J ; Chen, J.-J ; Peng, C.-Y ; Chien, R.-N ; Chen, P.-J

Journal of hepatology, 2017, Vol.66 (1), p.S56-S57 [Periódico revisado por pares]

Texto completo disponível

4
Predictors for clinical relapse within 2 year off-ETV therapy in HBeAg negative chronic hepatitis B patients
Material Type:
Artigo
Adicionar ao Meu Espaço

Predictors for clinical relapse within 2 year off-ETV therapy in HBeAg negative chronic hepatitis B patients

Jeng, W.-J ; Sheen, I-S ; Chen, Y.-C ; Liaw, Y.-F

Journal of hepatology, 2017, Vol.66 (1), p.S695-S695 [Periódico revisado por pares]

Texto completo disponível

5
A revisit of anti-HBc IgM in the differentiation of acute HBV infection from chronic HBV infection with acute flare-up
Material Type:
Artigo
Adicionar ao Meu Espaço

A revisit of anti-HBc IgM in the differentiation of acute HBV infection from chronic HBV infection with acute flare-up

Chen, Y.-C ; Lee, C.-H ; Hsieh, Y.-C ; Teng, W ; Huang, C.-H ; Jeng, W.-J ; Lin, C.-Y ; Sheen, I.-S

Journal of hepatology, 2017, Vol.66 (1), p.S685-S686 [Periódico revisado por pares]

Texto completo disponível

6
Multicenter Randomized Controlled Trial of Switching to Tenofovir Disoproxil Fumarate Monotherapy in Lamivudine-Resistant Chronic Hepatitis B Patients with Undetectable Hbv Viral Load under Lamivudine/Adefovir Add-On Therapy: Interim Analysis
Material Type:
Artigo
Adicionar ao Meu Espaço

Multicenter Randomized Controlled Trial of Switching to Tenofovir Disoproxil Fumarate Monotherapy in Lamivudine-Resistant Chronic Hepatitis B Patients with Undetectable Hbv Viral Load under Lamivudine/Adefovir Add-On Therapy: Interim Analysis

Huang, Y.-H ; Yu, M.-L ; Peng, C.-Y ; Chen, J.-J ; Chen, C.-Y ; Su, C.-W ; Lin, W.-Y ; Lai, H.-C ; Wang, Y.-J ; Dai, C.-Y ; Chuang, W.-L ; Lin, H.-C

Journal of hepatology, 2016, Vol.64 (2), p.S605-S605 [Periódico revisado por pares]

Texto completo disponível

7
Response at First Chemoembolization is a Robust Predictor of Favorable Outcome in Hepatocellular Carcinoma
Material Type:
Artigo
Adicionar ao Meu Espaço

Response at First Chemoembolization is a Robust Predictor of Favorable Outcome in Hepatocellular Carcinoma

Teng, W ; Hsieh, Y.-C ; Liu, K.-W ; Hung, C.-F ; Jeng, W.-J ; Huang, C.-H ; Chen, W.-T ; Chen, Y.-C ; Lin, C.-C ; Lin, C.-Y ; Lin, S.-M ; Sheen, I.-S

Journal of hepatology, 2016, Vol.64 (2), p.S703-S703 [Periódico revisado por pares]

Texto completo disponível

8
P655 GENDER DIFFERENCE IN THE EFFECT OF HEPATITIS B VIRUS GENOTYPE ON DISEASE PROGRESSION
Material Type:
Artigo
Adicionar ao Meu Espaço

P655 GENDER DIFFERENCE IN THE EFFECT OF HEPATITIS B VIRUS GENOTYPE ON DISEASE PROGRESSION

Jeng, R.W.-J ; Chen, Y.-C ; Liaw, Y.-F

Journal of hepatology, 2014-04, Vol.60 (1), p.S286-S287 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

9
P0345 : The role of cytokines and seromarkers in predicting HCC recurrence after radiofrequency ablation – interim report
Material Type:
Artigo
Adicionar ao Meu Espaço

P0345 : The role of cytokines and seromarkers in predicting HCC recurrence after radiofrequency ablation – interim report

Jeng, W.-J ; Chen, W.-T ; Lin, C.-C ; Huang, C.-H ; Teng, W ; Chen, Y.-C ; Hsu, C.-W ; Lin, C.-Y ; Lin, S.-M

Journal of hepatology, 2015-04, Vol.62, p.S439-S439 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

10
Phenotypic and genotypic shifts of hepatitis B virus in treatment naïve patients following extensive use of antivirals in a chronic Hepatitis B endemic area
Material Type:
Artigo
Adicionar ao Meu Espaço

Phenotypic and genotypic shifts of hepatitis B virus in treatment naïve patients following extensive use of antivirals in a chronic Hepatitis B endemic area

Yeh, C.-T ; Hsu, C.-W ; Lin, C.-L ; Liang, K.-H ; Lai, M.-W ; Chang, M.-L ; Lin, W.-R ; Chen, Y.-C

Journal of hepatology, 2017, Vol.66 (1), p.S472-S472 [Periódico revisado por pares]

Texto completo disponível

Resultados 1 2 3 4 5 next page

Buscando em bases de dados remotas. Favor aguardar.